SE8202947D0 - Forfarande for framstellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhallas genom detta forfarande och en farmaceutisk komposition - Google Patents

Forfarande for framstellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhallas genom detta forfarande och en farmaceutisk komposition

Info

Publication number
SE8202947D0
SE8202947D0 SE8202947A SE8202947A SE8202947D0 SE 8202947 D0 SE8202947 D0 SE 8202947D0 SE 8202947 A SE8202947 A SE 8202947A SE 8202947 A SE8202947 A SE 8202947A SE 8202947 D0 SE8202947 D0 SE 8202947D0
Authority
SE
Sweden
Prior art keywords
chondroitin polysulfate
procedure
relates
injectable
pharmaceutical composition
Prior art date
Application number
SE8202947A
Other languages
English (en)
Other versions
SE458118B (sv
SE8202947L (sv
Inventor
K H Wolf
Original Assignee
Luitpold Werk Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luitpold Werk Chem Pharm filed Critical Luitpold Werk Chem Pharm
Publication of SE8202947D0 publication Critical patent/SE8202947D0/sv
Publication of SE8202947L publication Critical patent/SE8202947L/sv
Publication of SE458118B publication Critical patent/SE458118B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8202947A 1981-05-11 1982-05-11 Foerfarande foer framstaellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhaallas genom detta foerfarande och en farmaceutisk komposition SE458118B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3118588A DE3118588C2 (de) 1981-05-11 1981-05-11 Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung

Publications (3)

Publication Number Publication Date
SE8202947D0 true SE8202947D0 (sv) 1982-05-11
SE8202947L SE8202947L (sv) 1982-11-12
SE458118B SE458118B (sv) 1989-02-27

Family

ID=6131969

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8202947A SE458118B (sv) 1981-05-11 1982-05-11 Foerfarande foer framstaellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhaallas genom detta foerfarande och en farmaceutisk komposition

Country Status (19)

Country Link
US (1) US4524066A (sv)
JP (1) JPS57192401A (sv)
AT (1) AT387225B (sv)
AU (1) AU552545B2 (sv)
BE (1) BE893097A (sv)
CA (1) CA1207758A (sv)
CH (1) CH650788A5 (sv)
DE (1) DE3118588C2 (sv)
DK (1) DK160317C (sv)
FI (1) FI70416C (sv)
FR (1) FR2505185B1 (sv)
GB (1) GB2098232B (sv)
IE (1) IE53633B1 (sv)
IL (1) IL65743A (sv)
IT (1) IT1157939B (sv)
LU (1) LU84143A1 (sv)
NL (1) NL186638C (sv)
NO (1) NO157147C (sv)
SE (1) SE458118B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244214A1 (de) * 1982-11-30 1984-05-30 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur reinigung und fraktionierung von heparin
US4623539A (en) * 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
CA1327354C (en) * 1987-03-19 1994-03-01 David Cullis-Hill Anti-inflamatory compounds and compositions
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5519010A (en) * 1989-02-06 1996-05-21 Taiho Pharmaceutical Co., Ltd. Sulfated polysaccharide, pharmaceutically acceptable salt thereof, process for preparing same and medicament containing same as effective component
ATE138938T1 (de) * 1989-02-06 1996-06-15 Taiho Pharmaceutical Co Ltd Sulfatiertes polysaccharid, dessen pharmazeutisch verträgliche salze, dessen herstellung und medikament, das dieses als wirksstoff enthält
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
JPH05279381A (ja) * 1991-09-13 1993-10-26 Dainippon Ink & Chem Inc 硫酸化オリゴ糖芳香族配糖体
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
US5591724A (en) * 1995-02-14 1997-01-07 Bioniche Inc. Method for treating the urinary bladder and associated structures using hyaluronic acid
IN181358B (sv) * 1995-02-14 1998-05-30 Bioniche Inc
WO2000056298A2 (en) * 1999-03-19 2000-09-28 Luitpold Pharmaceuticals, Inc. Treatment of lyme disease with polysulfated glycosaminoglycan formulations
SI1625135T1 (sl) * 2003-02-27 2009-08-31 Glaxo Group Ltd Sestavek natrijevega fondaparinuksa visoke äśistote
JP4679138B2 (ja) * 2004-12-24 2011-04-27 株式会社日本バリアフリー 高純度化されたムコ多糖類の製造方法
FR2969618B1 (fr) * 2010-12-28 2014-05-16 Pf Medicament Procede de preparation de chondroitine sulfate de sodium
RU2677330C2 (ru) * 2015-11-20 2019-01-16 Закрытое Акционерное Общество "Фармфирма "Сотекс" Способ приготовления инъекционной формы препарата хондроитина сульфата
WO2024072942A2 (en) 2022-09-29 2024-04-04 Adora Animal Health Corporation Skin penetrating formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE136572C (sv) * 1902-12-05
DE870094C (de) * 1950-10-17 1953-03-09 Geigy Ag J R Verfahren zur Herstellung von Polyschwefelsaeureestern des Chondroitins
DE935843C (de) * 1951-07-12 1955-12-01 Hoffmann La Roche Verfahren zur Herstellung eines blutgerinnungshemmenden Mittels
US2767167A (en) * 1953-07-06 1956-10-16 Gen Mills Inc Process of reducing the viscosity of gums
DE968752C (de) * 1954-01-29 1958-03-27 Hoffmann La Roche Verfahren zur Herstellung von Chondroitinpolyschwefelsaeureestern
US2803558A (en) * 1956-06-27 1957-08-20 Commw Color & Chemical Co Method of treating adhesive gums
US2959583A (en) * 1959-01-23 1960-11-08 Warner Lambert Pharmaceutical Method of purifying sulfated polysaccharides
US3175942A (en) * 1962-03-13 1965-03-30 Evans Medical Ltd Gastro-intestinal therapeutic
US3174904A (en) * 1963-03-25 1965-03-23 Rexall Drug Chemical Method of purifying sulfated carbohydrates
US3405120A (en) * 1966-01-27 1968-10-08 Green Cross Corp Low molecular chondroitin sulfate and method for manufacturing the same
US3454560A (en) * 1966-03-01 1969-07-08 Seikagaku Kogyo Co Ltd Process for the production of chondroitin polysulfate
BE857389A (fr) * 1977-08-02 1977-12-01 Marbex Finance Ltd Procede de preparation de chondroitines-sulfates de metaux alcalins et alcalino-terreux d'un poids moleculaire de 3000 a 6000

Also Published As

Publication number Publication date
AT387225B (de) 1988-12-27
DK160317B (da) 1991-02-25
FR2505185A1 (fr) 1982-11-12
DK160317C (da) 1991-08-05
FR2505185B1 (fr) 1986-02-28
SE458118B (sv) 1989-02-27
SE8202947L (sv) 1982-11-12
FI70416C (fi) 1986-09-19
IT8221189A0 (it) 1982-05-11
NL186638B (nl) 1990-08-16
GB2098232A (en) 1982-11-17
CA1207758A (en) 1986-07-15
FI821651A0 (fi) 1982-05-11
JPS57192401A (en) 1982-11-26
ATA184282A (de) 1988-05-15
IT1157939B (it) 1987-02-18
US4524066A (en) 1985-06-18
AU552545B2 (en) 1986-06-05
NO157147C (no) 1988-01-27
NO157147B (no) 1987-10-19
CH650788A5 (de) 1985-08-15
DE3118588C2 (de) 1983-07-07
IL65743A (en) 1985-09-29
NL186638C (nl) 1991-01-16
IL65743A0 (en) 1982-08-31
DE3118588A1 (de) 1982-12-02
GB2098232B (en) 1985-02-13
AU8357382A (en) 1982-11-18
DK211882A (da) 1982-11-12
JPH0261482B2 (sv) 1990-12-20
LU84143A1 (fr) 1982-09-13
FI821651L (fi) 1982-11-12
NO821551L (no) 1982-11-12
FI70416B (fi) 1986-03-27
NL8201873A (nl) 1982-12-01
IE821127L (en) 1982-11-11
IE53633B1 (en) 1989-01-04
BE893097A (fr) 1982-08-30

Similar Documents

Publication Publication Date Title
SE8202947L (sv) Forfarande for framstellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhallas genom detta forfarande och en farmaceutisk komposition
KR101314803B1 (ko) 술포알킬에테르 시클로덱스트린 조성물
DE69124590T2 (de) Glykosaminoglykan gemischt mit phospholipid oder lipid, seine herstellung und krebszellenmetastaseninhibitor
DE69610370T3 (de) Mit Antioxidantien gepfropfte Polysaccharide und deren Verwendungen
US5008253A (en) Sulfoamino derivatives of chondroitin sulfates of dermatan sulfate and of hyaluronic acid and their pharmacological properties
JP4861596B2 (ja) ヒアルロン酸オリゴ糖画分およびそれを含む医薬
BR9401920A (pt) Sal de sódio de uma heparina despolimerizada, processo para a preparação de uma fração de heparina processo para a preparação de uma heparina de baixo peso molecular, e, composição farmacêutica
JPH06506248A (ja) 新規な非抗凝固剤ヘパリン誘導体
DK77090A (da) Immunmodulerende azaspiraner
AU9137082A (en) Phenylcarboxylic acid derivatives
PT86191B (pt) Processo de preparacao controlada de glucosaminoglicanos de baixo peso molecular e de composicoes farmaceuticas
OA08170A (fr) Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues.
DE3863904D1 (de) Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.
IT8620846A0 (it) Derivati di acido valproico e di acido (e)-2-valproenoico, procedimento per la loro preparazione e relative composizioni farmaceutiche.
DD285606A5 (de) Verfahren zur herstellung von selektiv o-azylierten glucosaminoglycanen
ES2072163T3 (es) Compuestos de inclusion de acido 5,10-metilenotetrahidrofolico y ciclodextrina.
EP0305743A2 (de) Pharmazeutisches Kombinationspräparat sowie dessen Herstellung und Verwendung
DE69025691D1 (de) Einschlusskomplexe mit Silybinin, ihre Herstellung und pharmazeutische Präparate, die diese enthalten
Sethi et al. Studies on the anti-inflammatory and antiarthritic activity of Withaferin A
EP2717885B1 (de) Antiinfektives mittel
DE3921761A1 (de) Substituierte polysaccharide, verfahren zu deren herstellung sowie deren verwendung zur prophylaxe und behandlung von viruserkrankungen
DE3789290T2 (de) Theophyllinmethyldithiolan und Theophyllinmethyldithianylderivate, ein Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
IRIE et al. Reduction in the local tissue toxicity of chlorpromazine by β-cyclodextrin complexation
OA09794A (fr) Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments.
ES2056947T3 (es) Productos opticamente activos de derivados de 20,21-dinoreburnamenina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8202947-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8202947-1

Format of ref document f/p: F